Inspire Medical Shares Rise After CMS Reimbursement Update

Dow Jones02-27
 

By Josh Beckerman

 

Shares of Inspire Medical Systems closed the regular session higher after the Centers for Medicare and Medicaid Services issued a reimbursement update.

The stock gained 15%, to $68.05, Thursday. It has fallen about 65% over the past 12 months.

CMS said it is adding six new codes for hypoglossal nerve stimulators in the April 2026 Integrated Outpatient Code Editor, effective Jan. 1, 2026, according to KeyBanc Capital Markets, which called the development "directionally positive."

Meanwhile, Baird said the update limits "some of the reimbursement challenges that have weighed on" Inspire and Nyxoah. During the regular session, Nyxoah shares rose 5.6%, to $4.70.

 

Write to Josh Beckerman at josh.beckerman@wsj.com

 

(END) Dow Jones Newswires

February 26, 2026 18:27 ET (23:27 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment